Paramedic PapersHome Paediatrics Anonymous video deletion biased newborn RCT
Paediatrics
Anonymous video deletion biased newborn RCT
Selection bias introduced in a randomized clinical trial due to employee instigated deletion of newborn resuscitation videos
Resuscitation · Added 18 September 2026
Norwegian analysis of the NeoBeat RCT testing whether anonymous staff deletion of resuscitation videos introduced selection bias — after the anonymous opt-out, enrolled newborns had significantly higher Apgar scores, shorter ventilation and fewer admissions, and the trial was terminated halfway without power to conclude on its outcomes.
- Study type
- Other
- Design
- Analysis of selection bias within a randomised clinical trial (NeoBeat, Norway)
- Participants
- 9,909 newborns ≥34 weeks gestation (7,343 before, 2,566 after anonymous opt-out); 237 with video data
- Main finding
- After anonymous video deletion was introduced, enrolled newborns had significantly higher Apgar scores, shorter ventilation duration and fewer admissions; the trial was terminated halfway without power to conclude on its outcomes.
- Caveat
- Hospital-based newborn resuscitation trial; analysis limited by only 171 vs 66 video cases available.
- Bottom line
- Context only
Why it matters in Australia (Medium relevance). methodological finding on a neonatal resuscitation RCT rather than a practice change; useful caution for interpreting newborn resus evidence (CMG 5B context).
Learning goal
Understand how data integrity issues in newborn resuscitation research affect the trustworthiness of evidence I apply in practice.
More
- Topic: Paediatrics
- Daily scan: 18 September 2026
Related papers on Paediatrics
-
Paediatric air medical intubation performance
US national cohort of 1,040 paediatric air medical intubations — 86.5% first-pass success overall but only 69.1% in infants under 1, with ketamine the commonest induction agent and substantial site-to-site variation
-
Intranasal dexmedetomidine paediatric sedation
Townsville cohort of 114 children given intranasal dexmedetomidine for ED procedural sedation — effective as a sole agent in 78%, adverse events in 13% (mostly mild bradycardia), but ED stays ran long at a median 395 minutes
-
Paediatric IV ketamine sedation very safe
Systematic review of 20 studies covering 67,871 children having IV ketamine procedural sedation in EDs — no deaths or permanent adverse outcomes, sentinel events pooled at about 1 in 11,558 sedations, serious adverse events 0.34%, with age ≥10, upper respiratory infection and opioid co-administration modest predictors while ASA status and benzodiazepine co-administration were not.
-
Delphi consensus on paediatric procedural sedation
Two-round Delphi consensus of 28 paediatric emergency clinicians from 23 Spanish centres — strong agreement on monitoring standards, staffing and safety requirements for paediatric procedural sedation, with ketamine the preferred agent for painful procedures.